US Stock MarketDetailed Quotes

KTTA Pasithea Therapeutics

Watchlist
  • 2.9500
  • +0.2200+8.06%
Close Dec 30 16:00 ET
  • 3.1001
  • +0.1501+5.09%
Post 19:55 ET
3.74MMarket Cap-0.20P/E (TTM)

Pasithea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.63%-3.12M
-31.15%-4.04M
-34.94%-4.32M
-7.73%-12.81M
-3.42%-3.29M
29.94%-3.24M
-59.12%-3.08M
-48.79%-3.2M
-274.74%-11.89M
-82.61%-3.19M
Net income from continuing operations
16.96%-3M
-7.45%-3.87M
-18.22%-3.86M
-32.23%-15.51M
-24.12%-5.03M
13.80%-3.61M
-64.31%-3.6M
-152.46%-3.27M
-439.58%-11.73M
-743.25%-4.05M
Operating gains losses
256.25%70.31K
119.96%35.62K
-157.00%-26.72K
93.45%-121.29K
105.64%55.31K
-113.42%-45K
57.68%-178.47K
105.97%46.87K
20.66%-1.85M
62.09%-980.51K
Depreciation and amortization
0.00%162.26K
-0.00%162.26K
0.33%162.26K
12,629.76%648.45K
3,820.28%162.22K
16,225,700.00%162.26K
16,854.75%162.26K
--161.72K
269.40%5.09K
200.07%4.14K
Other non cash items
----
----
----
----
----
--960
--960
96,100.00%960
----
----
Change In working capital
-485.87%-501.06K
-268.69%-531.45K
-191.69%-942.26K
86.22%1.57M
-13.97%1.45M
117.32%129.85K
171.95%315.04K
-54.63%-323.04K
659.97%845.35K
3,028.64%1.69M
-Change in receivables
----
----
--0
----
----
----
----
---15.78K
----
----
-Change in prepaid assets
247.20%250.97K
2,107.89%468.16K
-200.84%-822.51K
291.03%346.48K
57.54%769.17K
67.94%-170.49K
-78.95%21.2K
-14.65%-273.4K
44.95%-181.37K
262.27%488.25K
-Change in payables and accrued expense
-1,572.63%-758.35K
-322.39%-1.04M
-249.64%-118.37K
43.61%1.07M
143.76%682.9K
-111.18%-45.34K
1,437.84%467.26K
-214.56%-33.86K
69.23%745.76K
446.66%280.15K
-Change in other current assets
-98.17%6.32K
121.40%40.5K
--58
160.19%158.29K
-99.50%1.8K
160.15%345.68K
---189.2K
--0
---262.99K
--358.29K
-Change in other current liabilities
--0
---963
---1.45K
-100.28%-1.55K
-100.28%-1.55K
--0
--0
--0
--543.96K
--561.52K
Cash from discontinued investing activities
0
0
0
-11.25K
-3,836.11%-399.69K
55.39%-183.44K
Operating cash flow
3.96%-3.12M
-16.08%-4.04M
-27.63%-4.32M
-7.73%-12.81M
15.24%-2.7M
23.03%-3.25M
-80.77%-3.48M
-32.08%-3.39M
-274.74%-11.89M
-82.61%-3.19M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
103.27%75.2K
102.33%54.54K
293.16%50.16K
-65.21%24.39K
-2,662.07%-53.89K
-10,594.78%-2.3M
-18,007.96%-2.34M
Net PPE purchase and sale
--0
--0
--0
67.97%-34.3K
100.04%36
513.03%22.66K
55.21%-3.11K
-2,662.07%-53.89K
-398.07%-107.1K
-616.96%-92.73K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---2.19M
---2.25M
Net other investing changes
----
----
----
--109.5K
--54.5K
--27.5K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
113.63%399.01K
102.40%54.54K
126.98%50.16K
194.99%344.01K
54.19%-49.7K
-13,510.18%-2.93M
-17,452.08%-2.27M
Financing cash flow
Cash flow from continuing financing activities
217.65%4.54M
0
0
-16.22%-3.73M
0
-3.86M
-130.77K
264.1K
-105.73%-3.21M
-109.38%-3.21M
Net issuance payments of debt
--0
--0
--0
--0
--0
---133.34K
---130.77K
--264.1K
--0
--0
Net common stock issuance
----
----
----
-16.22%-3.73M
--0
----
----
----
-106.38%-3.21M
-111.80%-3.21M
Cash from discontinued financing activities
65.98%-611.28K
-1.8M
-769.68K
Financing cash flow
217.65%4.54M
--0
--0
13.30%-4.34M
84.63%-611.28K
-275.86%-3.86M
---130.77K
--264.1K
-108.94%-5M
-111.64%-3.98M
Net cash flow
Beginning cash position
-70.10%7.97M
-59.85%12.01M
-50.64%16.33M
-37.45%33.09M
-53.79%19.58M
-44.36%26.65M
-40.44%29.91M
-37.45%33.09M
21,612.28%52.9M
106.07%42.38M
Current changes in cash
120.13%1.42M
-23.66%-4.04M
-36.26%-4.32M
15.49%-16.75M
65.47%-3.26M
-29.90%-7.06M
-42.82%-3.27M
-18.69%-3.17M
-137.59%-19.82M
-129.10%-9.43M
Effect of exchange rate changes
-537.52%-27.13K
-818.61%-2.91K
75.03%-620
-140.31%-3.99K
-97.80%3.07K
94.84%-4.26K
99.25%-317
44.98%-2.48K
193.74%9.9K
2,150.61%139.42K
End cash Position
-52.20%9.36M
-70.10%7.97M
-59.85%12.01M
-50.64%16.33M
-50.64%16.33M
-53.79%19.58M
-44.36%26.65M
-40.44%29.91M
-37.53%33.09M
-37.53%33.09M
Free cash flow
3.28%-3.12M
-15.98%-4.04M
-25.63%-4.32M
-7.06%-12.85M
17.64%-2.7M
23.66%-3.23M
-80.28%-3.48M
-34.08%-3.44M
-275.57%-12M
-86.55%-3.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.63%-3.12M-31.15%-4.04M-34.94%-4.32M-7.73%-12.81M-3.42%-3.29M29.94%-3.24M-59.12%-3.08M-48.79%-3.2M-274.74%-11.89M-82.61%-3.19M
Net income from continuing operations 16.96%-3M-7.45%-3.87M-18.22%-3.86M-32.23%-15.51M-24.12%-5.03M13.80%-3.61M-64.31%-3.6M-152.46%-3.27M-439.58%-11.73M-743.25%-4.05M
Operating gains losses 256.25%70.31K119.96%35.62K-157.00%-26.72K93.45%-121.29K105.64%55.31K-113.42%-45K57.68%-178.47K105.97%46.87K20.66%-1.85M62.09%-980.51K
Depreciation and amortization 0.00%162.26K-0.00%162.26K0.33%162.26K12,629.76%648.45K3,820.28%162.22K16,225,700.00%162.26K16,854.75%162.26K--161.72K269.40%5.09K200.07%4.14K
Other non cash items ----------------------960--96096,100.00%960--------
Change In working capital -485.87%-501.06K-268.69%-531.45K-191.69%-942.26K86.22%1.57M-13.97%1.45M117.32%129.85K171.95%315.04K-54.63%-323.04K659.97%845.35K3,028.64%1.69M
-Change in receivables ----------0-------------------15.78K--------
-Change in prepaid assets 247.20%250.97K2,107.89%468.16K-200.84%-822.51K291.03%346.48K57.54%769.17K67.94%-170.49K-78.95%21.2K-14.65%-273.4K44.95%-181.37K262.27%488.25K
-Change in payables and accrued expense -1,572.63%-758.35K-322.39%-1.04M-249.64%-118.37K43.61%1.07M143.76%682.9K-111.18%-45.34K1,437.84%467.26K-214.56%-33.86K69.23%745.76K446.66%280.15K
-Change in other current assets -98.17%6.32K121.40%40.5K--58160.19%158.29K-99.50%1.8K160.15%345.68K---189.2K--0---262.99K--358.29K
-Change in other current liabilities --0---963---1.45K-100.28%-1.55K-100.28%-1.55K--0--0--0--543.96K--561.52K
Cash from discontinued investing activities 000-11.25K-3,836.11%-399.69K55.39%-183.44K
Operating cash flow 3.96%-3.12M-16.08%-4.04M-27.63%-4.32M-7.73%-12.81M15.24%-2.7M23.03%-3.25M-80.77%-3.48M-32.08%-3.39M-274.74%-11.89M-82.61%-3.19M
Investing cash flow
Cash flow from continuing investing activities 000103.27%75.2K102.33%54.54K293.16%50.16K-65.21%24.39K-2,662.07%-53.89K-10,594.78%-2.3M-18,007.96%-2.34M
Net PPE purchase and sale --0--0--067.97%-34.3K100.04%36513.03%22.66K55.21%-3.11K-2,662.07%-53.89K-398.07%-107.1K-616.96%-92.73K
Net business purchase and sale --------------0-------------------2.19M---2.25M
Net other investing changes --------------109.5K--54.5K--27.5K----------------
Cash from discontinued investing activities
Investing cash flow --0--0--0113.63%399.01K102.40%54.54K126.98%50.16K194.99%344.01K54.19%-49.7K-13,510.18%-2.93M-17,452.08%-2.27M
Financing cash flow
Cash flow from continuing financing activities 217.65%4.54M00-16.22%-3.73M0-3.86M-130.77K264.1K-105.73%-3.21M-109.38%-3.21M
Net issuance payments of debt --0--0--0--0--0---133.34K---130.77K--264.1K--0--0
Net common stock issuance -------------16.22%-3.73M--0-------------106.38%-3.21M-111.80%-3.21M
Cash from discontinued financing activities 65.98%-611.28K-1.8M-769.68K
Financing cash flow 217.65%4.54M--0--013.30%-4.34M84.63%-611.28K-275.86%-3.86M---130.77K--264.1K-108.94%-5M-111.64%-3.98M
Net cash flow
Beginning cash position -70.10%7.97M-59.85%12.01M-50.64%16.33M-37.45%33.09M-53.79%19.58M-44.36%26.65M-40.44%29.91M-37.45%33.09M21,612.28%52.9M106.07%42.38M
Current changes in cash 120.13%1.42M-23.66%-4.04M-36.26%-4.32M15.49%-16.75M65.47%-3.26M-29.90%-7.06M-42.82%-3.27M-18.69%-3.17M-137.59%-19.82M-129.10%-9.43M
Effect of exchange rate changes -537.52%-27.13K-818.61%-2.91K75.03%-620-140.31%-3.99K-97.80%3.07K94.84%-4.26K99.25%-31744.98%-2.48K193.74%9.9K2,150.61%139.42K
End cash Position -52.20%9.36M-70.10%7.97M-59.85%12.01M-50.64%16.33M-50.64%16.33M-53.79%19.58M-44.36%26.65M-40.44%29.91M-37.53%33.09M-37.53%33.09M
Free cash flow 3.28%-3.12M-15.98%-4.04M-25.63%-4.32M-7.06%-12.85M17.64%-2.7M23.66%-3.23M-80.28%-3.48M-34.08%-3.44M-275.57%-12M-86.55%-3.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+1.72%
Petroleo Brasileiro SA Petrobras
PBR
+1.11%
Taylor Morrison Home
TMHC
+0.76%
NVIDIA
NVDA
+0.35%
Adobe
ADBE
-0.15%

Unlock the Full List